![](/img/cover-not-exists.png)
Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.
Jones, S E, Schottstaedt, M W, Duncan, L A, Kirby, R L, Good, R H, Mennel, R G, George, T K, Snyder, D A, Watkins, D L, Denham, C A, Hoyes, F A, Rubin, A SVolume:
14
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1996.14.11.2976
Date:
November, 1996
File:
PDF, 656 KB
1996